Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
A legfontosabb adatok
- Ki végzi
- Northwestern University
- Hol
- Chicago (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Fut, nem toboroz
- Fázis
- 4. fázis
- Résztvevők
- 20 fő, tervezett
- Kezdés
- 2022. aug. 24.
- Várható befejezés
- 2027. szept. 1.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Naproxen 500 Mg
- Placebo
- A regiszteradat frissítve
- 2026. március 23.
Ki vehet részt
- Életkor
- 40 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter összes feltétele (37)A regiszter feltételeinek elrejtése
Ki vehet részt
- Male or female >40 years of age
- Meet ACR criteria for knee OA
- Able and willing to provide informed consent
- Average weekly pain in the index knee based on daily pain assessments of ≥ 4/10 and <9/10 on an 11-point NRS scale
- Willing to discontinue current medications taken for OA pain
- For women of child-bearing potential, willing to utilize some form of birth control or abstinence during the course of the study
- If taking cannabinoids, have to be on a stable dose and have this maintained for the duration of the study
- If receiving physical therapy or any non-pharmacologic modality(ies) for OA, these need to continue and remain stable for the duration of the study
- Ambulatory
- Have a cellphone and/or access to a computer and be able to utilize the eDiary as directed
- Use of medications for knee OA pain on at least 4 out of 7 days per week
- eDiary entries on at least 4 out 7 days per week during the observation period
- Sub-Group Criterion (≥12 participants): Variability of average daily pain in the index knee during the observation period of ≥ 2 points on the NRS scale on at least 4 occasions
Ki nem vehet részt
- Previous history of GI bleed
- Use of recreational drugs
- Index knee cannot have had previous joint replacement surgery
- Corticosteroid injection in the index knee in the past 3 months
- History of intolerance or allergic reaction to NSAIDs
- History of myocardial infarction in last 6 months
- Coexisting congestive heart failure or symptomatic atherosclerotic heart disease
- Use of oral anticoagulants other than aspirin ≤ 325 mg for cardiac prophylaxis
- Uncontrolled hypertension
- Any medical condition which in the judgement of the investigator would make it inappropriate for the participant to enroll in the study
- Participation in another clinical trial other than one for covid or an observational and non-interventional study
- Any acute or chronic pain condition which would interfere with the evaluation of knee pain
- Renal insufficiency resulting in serum creatinine > 1.5 mg/dL
- Use of heparin or injectable anticoagulant
- Fibromyalgia
- Inflammatory arthropathies of any sort
- Chronic back pain in which pain level is greater than the OA pain
- Use of walker or other aid for walking other than a single cane
- Hip pain on the ipsilateral side equal to or greater than the knee pain in the index joint
- Arthroscopy within the past 6 months
- Injection of hyaluronate in the index knee in the past 6 months
- Injection of any biologic agent in the index in the past 12 months
- Nerve ablation for the treatment of pain in the index knee
- Pregnant, nursing or planning to become pregnant during length of study
Helyszínek itt: Egyesült Államok
- Northwestern University Feinberg School of MedicineChicago, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This is a pilot study with a 4-period double-cross-over design evaluating a treatment with non-steroidal anti-inflammatory drugs (NSAIDs) in people with painful knee osteoarthritis.
A vizsgálat 2 csoportja
- Cross-over Treatment: Initial treatment with naproxenA vizsgált kezelés
There will be a 4 period cross-over: 2 weeks of treatment with IP, followed by 2 weeks of washout, and this repeated 3 more times. Treatment will be such that all participants will receive 2 treatment periods with naproxen and 2 treatment periods with placebo. The order of treatment will be randomized and the treatment allocation and IP will be blinded.
Kezelés: Naproxen 500 Mg és Placebo
- Cross-over Treatment: Initial treatment with placeboA vizsgált kezelés
There will be a 4 period cross-over: 2 weeks of treatment with IP, followed by 2 weeks of washout, and this repeated 3 more times. Treatment will be such that all participants will receive 2 treatment periods with naproxen and 2 treatment periods with placebo. The order of treatment will be randomized and the treatment allocation and IP will be blinded.
Kezelés: Naproxen 500 Mg és Placebo
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- N of 1 Pilot Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
- A regiszteradat frissítve
- 2026. március 23.